Additional file 12: of First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors

Shitara, Kohei; Ueha, Satoshi; Shichino, Shigeyuki; Aoki, Hiroyasu; Ogiwara, Haru; Nakatsura, Tetsuya; Suzuki, Toshihiro; Shimomura, Manami; Yoshikawa, Toshiaki; Shoda, Kayoko; Kitano, Shigehisa; Yamashita, Makiko; Nakayama, Takayuki; Sato, Akihiro; Kuroda, Sakiko; Wakabayashi, Masashi; Nomura, Shogo; Yokochi, Shoji; Ito, Satoru; Matsushima, Kouji; Doi, Toshihiko

doi:10.6084/m9.figshare.9043688.v1

40425_2019_677_MOESM12_ESM.docx (19.24 kB)

Additional file 12: of First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors

journal contribution

posted on 2019-07-25, 06:27 authored by Kohei Shitara, Satoshi Ueha, Shigeyuki Shichino, Hiroyasu Aoki, Haru Ogiwara, Tetsuya Nakatsura, Toshihiro Suzuki, Manami Shimomura, Toshiaki Yoshikawa, Kayoko Shoda, Shigehisa Kitano, Makiko Yamashita, Takayuki Nakayama, Akihiro Sato, Sakiko Kuroda, Masashi Wakabayashi, Shogo Nomura, Shoji Yokochi, Satoru Ito, Kouji Matsushima, Toshihiko Doi

Table S4. Summary of TCR sequencing of tumor biopsy samples. (DOCX 19 kb)

Funding

Japan Agency for Medical Research and Development (AMED)

History

Usage metrics

Keywords

Anti-CD4 antibody CD4+ T cells CD8+ T cells Immunotherapy

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 12: of First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors

Funding

Japan Agency for Medical Research and Development (AMED)

History

Usage metrics

Categories

Keywords

Licence

Exports